CURLF
Price
$2.35
Change
-$0.19 (-7.48%)
Updated
Sep 26 closing price
Capitalization
1.82B
38 days until earnings call
GRUSF
Price
$0.39
Change
-$0.04 (-9.30%)
Updated
Sep 26 closing price
Capitalization
98.45M
Interact to see
Advertisement

CURLF vs GRUSF

Header iconCURLF vs GRUSF Comparison
Open Charts CURLF vs GRUSFBanner chart's image
Curaleaf
Price$2.35
Change-$0.19 (-7.48%)
Volume$620.17K
Capitalization1.82B
Grown Rogue International
Price$0.39
Change-$0.04 (-9.30%)
Volume$422.82K
Capitalization98.45M
CURLF vs GRUSF Comparison Chart in %
Loading...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CURLF vs. GRUSF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURLF is a Hold and GRUSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CURLF: $2.35 vs. GRUSF: $0.39)
Brand notoriety: CURLF and GRUSF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CURLF: 46% vs. GRUSF: 277%
Market capitalization -- CURLF: $1.82B vs. GRUSF: $98.45M
CURLF [@Pharmaceuticals: Generic] is valued at $1.82B. GRUSF’s [@Pharmaceuticals: Generic] market capitalization is $98.45M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURLF’s FA Score shows that 0 FA rating(s) are green whileGRUSF’s FA Score has 0 green FA rating(s).

  • CURLF’s FA Score: 0 green, 5 red.
  • GRUSF’s FA Score: 0 green, 5 red.
According to our system of comparison, CURLF is a better buy in the long-term than GRUSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURLF’s TA Score shows that 4 TA indicator(s) are bullish while GRUSF’s TA Score has 4 bullish TA indicator(s).

  • CURLF’s TA Score: 4 bullish, 5 bearish.
  • GRUSF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GRUSF is a better buy in the short-term than CURLF.

Price Growth

CURLF (@Pharmaceuticals: Generic) experienced а -9.62% price change this week, while GRUSF (@Pharmaceuticals: Generic) price change was -12.44% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

CURLF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($1.82B) has a higher market cap than GRUSF($98.5M). CURLF YTD gains are higher at: 50.641 vs. GRUSF (-39.806). CURLF has higher annual earnings (EBITDA): 220M vs. GRUSF (10.2M). CURLF has more cash in the bank: 102M vs. GRUSF (9.25M). GRUSF has less debt than CURLF: GRUSF (13.2M) vs CURLF (843M). CURLF has higher revenues than GRUSF: CURLF (1.29B) vs GRUSF (23.8M).
CURLFGRUSFCURLF / GRUSF
Capitalization1.82B98.5M1,843%
EBITDA220M10.2M2,157%
Gain YTD50.641-39.806-127%
P/E RatioN/A19.70-
Revenue1.29B23.8M5,403%
Total Cash102M9.25M1,102%
Total Debt843M13.2M6,386%
FUNDAMENTALS RATINGS
CURLF vs GRUSF: Fundamental Ratings
CURLF
GRUSF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
61
Fair valued
PROFIT vs RISK RATING
1..100
10061
SMR RATING
1..100
9754
PRICE GROWTH RATING
1..100
3665
P/E GROWTH RATING
1..100
10071
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (48) in the null industry is in the same range as GRUSF (61). This means that CURLF’s stock grew similarly to GRUSF’s over the last 12 months.

GRUSF's Profit vs Risk Rating (61) in the null industry is somewhat better than the same rating for CURLF (100). This means that GRUSF’s stock grew somewhat faster than CURLF’s over the last 12 months.

GRUSF's SMR Rating (54) in the null industry is somewhat better than the same rating for CURLF (97). This means that GRUSF’s stock grew somewhat faster than CURLF’s over the last 12 months.

CURLF's Price Growth Rating (36) in the null industry is in the same range as GRUSF (65). This means that CURLF’s stock grew similarly to GRUSF’s over the last 12 months.

GRUSF's P/E Growth Rating (71) in the null industry is in the same range as CURLF (100). This means that GRUSF’s stock grew similarly to CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURLFGRUSF
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRUSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WMKSX17.630.22
+1.26%
WesMark Small Company Fund
FASDX18.080.10
+0.56%
Fidelity Advisor Strategic Div & Inc A
GSPUX45.120.21
+0.47%
Goldman Sachs Large Cap Equity R6
MPLIX15.750.06
+0.38%
Praxis International Index I
CMRCX10.64N/A
N/A
Calamos Merger Arbitrage C

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
-7.35%
GTBIF - CURLF
82%
Closely correlated
-2.02%
TCNNF - CURLF
78%
Closely correlated
+1.09%
VRNOF - CURLF
76%
Closely correlated
-1.72%
CRLBF - CURLF
73%
Closely correlated
-1.90%
TSNDF - CURLF
73%
Closely correlated
-2.69%
More

GRUSF and

Correlation & Price change

A.I.dvisor tells us that GRUSF and GLASF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GRUSF and GLASF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRUSF
1D Price
Change %
GRUSF100%
-8.37%
GLASF - GRUSF
32%
Poorly correlated
-0.46%
CRLBF - GRUSF
29%
Poorly correlated
-1.90%
CURLF - GRUSF
28%
Poorly correlated
-7.35%
TSNDF - GRUSF
27%
Poorly correlated
-2.69%
CXXIF - GRUSF
25%
Poorly correlated
-5.04%
More